Genespire
PrivateLast Round
Series B
Sep 25, 2024
Total Funding Raised
$69.39M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Genespire operates in Healthcare & Life Sciences and is based in Milan. Its latest recorded funding round was a Series B round in September 2024.
Genespire is a biotechnology company that develops off-the-shelf gene therapies for pediatric patients affected by genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genespire Comparables
Compare Genespire with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iECURE | 81% | |
| Eli Lilly and Company | 78% | |
| Vivet Therapeutics | 77% |
For institutional investors. Book with your work email.
Genespire Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 25, 2024 | ||||
| Series A | Apr 29, 2020 |
For institutional investors. Book with your work email.
Genespire Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| XGEN Venture | Series B |
| Indaco Venture Partners SGR | Series B |
| CDP Venture Capital SGR | Series B |
| Sofinnova Partners | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 286% MoM, from 317 to 1.2K.
- Apr 4, 2026
Monthly visitors increased 54% MoM.
For institutional investors. Book with your work email.
Genespire Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Genespire's valuation, stock price, and market status.
Is Genespire a public or private company?
Genespire is a private company.
What is the current stock price of Genespire?
Genespire is a private company, so its shares have no public market price. Caplight tracks Genespire's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genespire worth (valuation)?
Valuation information for Genespire is not publicly available.
Can I buy Genespire stock?
Genespire shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genespire's last funding round?
Genespire's most recent funding round was Series B on September 25, 2024.
Who are the main investors in Genespire?
Key investors in Genespire include XGEN Venture, CDP Venture Capital SGR, Sofinnova Partners.
Will Genespire IPO soon?
No public IPO plans have been announced for Genespire.
How can I track Genespire secondary market activity?
Caplight tracks bids, offers, and trades in Genespire's shares on secondary markets.